This week we have on Josh Nicholson, former cancer researcher & CEO of scite.ai. scite combines deep learning with a network of experts to evaluate the veracity of scientific work. With a PH.D in Cell Biology & as a former cancer researcher himself, Josh knows the challenges of drug discovery and has been dedicated to improving the industry. By building a transparent and reliable community, scite is making science reliable again.

This week we have on Josh Nicholson, former cancer researcher &amp; CEO of scite.ai. scite combines deep learning with a network of experts to evaluate the veracity of scientific work. With a PH.D in Cell Biology &amp; as a former cancer researcher himself, Josh knows the challenges of drug discovery and has been dedicated to improving the industry. By building a transparent and reliable community, scite is making science reliable again.

How Scite.ai is Making Science Reliable Again

AI in the Wild, a weekly discovery show focused on helping professionals across industries implement AI technology in their organizations. Through focused interviews with founders, investors, and corporate executives, we distill complex AI technology down to basic business solutions. To stay up to date on new shows sign up to our newsletter at https://nyc.ai/portfolio/podcast/.

Share How Scite.ai is Making Science Reliable Again

Sign up to save your podcasts

How Scite.ai is Making Science Reliable Again

How Scite.ai is Making Science Reliable Again